nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolpidem—CYP3A5—Beclomethasone—psoriasis	0.0637	0.0957	CbGbCtD
Zolpidem—CYP1A2—Clobetasol propionate—psoriasis	0.0626	0.094	CbGbCtD
Zolpidem—CYP1A2—Methoxsalen—psoriasis	0.0329	0.0494	CbGbCtD
Zolpidem—CYP2D6—Hydroxyurea—psoriasis	0.0296	0.0445	CbGbCtD
Zolpidem—CYP3A7—Hydrocortisone—psoriasis	0.0271	0.0408	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0271	0.0408	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0256	0.0385	CbGbCtD
Zolpidem—CYP3A7—Cyclosporine—psoriasis	0.0256	0.0385	CbGbCtD
Zolpidem—CYP3A5—Mycophenolate mofetil—psoriasis	0.0254	0.0381	CbGbCtD
Zolpidem—CYP2C19—Cholecalciferol—psoriasis	0.0236	0.0355	CbGbCtD
Zolpidem—CYP3A4—Calcitriol—psoriasis	0.0221	0.0333	CbGbCtD
Zolpidem—CYP3A5—Hydrocortisone—psoriasis	0.0204	0.0306	CbGbCtD
Zolpidem—CYP2C9—Cholecalciferol—psoriasis	0.0196	0.0295	CbGbCtD
Zolpidem—CYP3A5—Cyclosporine—psoriasis	0.0192	0.0289	CbGbCtD
Zolpidem—CYP2D6—Cholecalciferol—psoriasis	0.0179	0.027	CbGbCtD
Zolpidem—CYP3A4—Methoxsalen—psoriasis	0.0172	0.0259	CbGbCtD
Zolpidem—CYP3A7—Dexamethasone—psoriasis	0.0169	0.0254	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0169	0.0254	CbGbCtD
Zolpidem—CYP2C19—Prednisone—psoriasis	0.0164	0.0246	CbGbCtD
Zolpidem—CYP2C19—Cyclosporine—psoriasis	0.0155	0.0233	CbGbCtD
Zolpidem—CYP2C9—Cyclosporine—psoriasis	0.0129	0.0194	CbGbCtD
Zolpidem—CYP3A5—Dexamethasone—psoriasis	0.0127	0.019	CbGbCtD
Zolpidem—CYP2D6—Cyclosporine—psoriasis	0.0118	0.0177	CbGbCtD
Zolpidem—CYP3A4—Cholecalciferol—psoriasis	0.0114	0.0171	CbGbCtD
Zolpidem—CYP2C19—Dexamethasone—psoriasis	0.0102	0.0153	CbGbCtD
Zolpidem—CYP3A4—Mycophenolate mofetil—psoriasis	0.00989	0.0149	CbGbCtD
Zolpidem—CYP3A4—Triamcinolone—psoriasis	0.00989	0.0149	CbGbCtD
Zolpidem—CYP2C9—Dexamethasone—psoriasis	0.00849	0.0128	CbGbCtD
Zolpidem—CYP3A4—Betamethasone—psoriasis	0.00848	0.0128	CbGbCtD
Zolpidem—CYP3A4—Prednisolone—psoriasis	0.00837	0.0126	CbGbCtD
Zolpidem—CYP3A4—Hydrocortisone—psoriasis	0.00794	0.0119	CbGbCtD
Zolpidem—CYP3A4—Prednisone—psoriasis	0.00791	0.0119	CbGbCtD
Zolpidem—CYP2D6—Dexamethasone—psoriasis	0.00776	0.0117	CbGbCtD
Zolpidem—CYP3A4—Cyclosporine—psoriasis	0.00749	0.0113	CbGbCtD
Zolpidem—Tolmetin—CXCL8—psoriasis	0.00514	1	CrCbGaD
Zolpidem—CYP3A4—Dexamethasone—psoriasis	0.00494	0.00742	CbGbCtD
Zolpidem—CYP3A7—Xenobiotics—CYP2S1—psoriasis	0.000783	0.0518	CbGpPWpGaD
Zolpidem—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.000706	0.0467	CbGpPWpGaD
Zolpidem—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.000649	0.043	CbGpPWpGaD
Zolpidem—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.000643	0.0426	CbGpPWpGaD
Zolpidem—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.000605	0.0401	CbGpPWpGaD
Zolpidem—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.000566	0.0374	CbGpPWpGaD
Zolpidem—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.000437	0.0289	CbGpPWpGaD
Zolpidem—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.000402	0.0266	CbGpPWpGaD
Zolpidem—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000399	0.0264	CbGpPWpGaD
Zolpidem—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000341	0.0226	CbGpPWpGaD
Zolpidem—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000325	0.0215	CbGpPWpGaD
Zolpidem—CYP3A7—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000321	0.0212	CbGpPWpGaD
Zolpidem—CYP3A7—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000263	0.0174	CbGpPWpGaD
Zolpidem—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000263	0.0174	CbGpPWpGaD
Zolpidem—PTGS1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000255	0.0169	CbGpPWpGaD
Zolpidem—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000235	0.0155	CbGpPWpGaD
Zolpidem—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000232	0.0153	CbGpPWpGaD
Zolpidem—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00019	0.0126	CbGpPWpGaD
Zolpidem—PTGS1—Overview of nanoparticle effects—CRP—psoriasis	0.000188	0.0125	CbGpPWpGaD
Zolpidem—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000182	0.012	CbGpPWpGaD
Zolpidem—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000179	0.0119	CbGpPWpGaD
Zolpidem—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000167	0.0111	CbGpPWpGaD
Zolpidem—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000166	0.011	CbGpPWpGaD
Zolpidem—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000165	0.0109	CbGpPWpGaD
Zolpidem—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000163	0.0108	CbGpPWpGaD
Zolpidem—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000147	0.00975	CbGpPWpGaD
Zolpidem—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000142	0.00937	CbGpPWpGaD
Zolpidem—CYP3A7—Biological oxidations—CYP2S1—psoriasis	0.00014	0.00926	CbGpPWpGaD
Zolpidem—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00014	0.00924	CbGpPWpGaD
Zolpidem—GABRB2—Orphan transporters—CARM1—psoriasis	0.000139	0.0092	CbGpPWpGaD
Zolpidem—CYP3A7—Metapathway biotransformation—CYP2S1—psoriasis	0.000138	0.00914	CbGpPWpGaD
Zolpidem—PTGS1—Biological oxidations—CYP2S1—psoriasis	0.000136	0.00898	CbGpPWpGaD
Zolpidem—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000135	0.00896	CbGpPWpGaD
Zolpidem—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000134	0.00889	CbGpPWpGaD
Zolpidem—GABRA3—Orphan transporters—CARM1—psoriasis	0.000133	0.00878	CbGpPWpGaD
Zolpidem—GABRA2—Orphan transporters—CARM1—psoriasis	0.00013	0.00863	CbGpPWpGaD
Zolpidem—GABRB3—Orphan transporters—CARM1—psoriasis	0.000129	0.00857	CbGpPWpGaD
Zolpidem—GABRG2—Orphan transporters—CARM1—psoriasis	0.000127	0.00842	CbGpPWpGaD
Zolpidem—PTGS1—Overview of nanoparticle effects—CXCL8—psoriasis	0.000123	0.00811	CbGpPWpGaD
Zolpidem—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000115	0.00759	CbGpPWpGaD
Zolpidem—GABRA1—Orphan transporters—CARM1—psoriasis	0.000111	0.00736	CbGpPWpGaD
Zolpidem—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000109	0.00723	CbGpPWpGaD
Zolpidem—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000108	0.00713	CbGpPWpGaD
Zolpidem—CYP3A5—Biological oxidations—CYP2S1—psoriasis	0.000101	0.0067	CbGpPWpGaD
Zolpidem—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	9.98e-05	0.0066	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—RUNX3—psoriasis	9.45e-05	0.00626	CbGpPWpGaD
Zolpidem—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	8.85e-05	0.00586	CbGpPWpGaD
Zolpidem—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	8.73e-05	0.00578	CbGpPWpGaD
Zolpidem—PTGS1—Overview of nanoparticle effects—TNF—psoriasis	8.53e-05	0.00565	CbGpPWpGaD
Zolpidem—Myalgia—Betamethasone—psoriasis	7.84e-05	0.000249	CcSEcCtD
Zolpidem—Abdominal pain—Cyclosporine—psoriasis	7.83e-05	0.000249	CcSEcCtD
Zolpidem—Body temperature increased—Cyclosporine—psoriasis	7.83e-05	0.000249	CcSEcCtD
Zolpidem—CYP2C19—Biological oxidations—CYP2S1—psoriasis	7.82e-05	0.00518	CbGpPWpGaD
Zolpidem—Anxiety—Dexamethasone—psoriasis	7.81e-05	0.000249	CcSEcCtD
Zolpidem—Anxiety—Betamethasone—psoriasis	7.81e-05	0.000249	CcSEcCtD
Zolpidem—Vomiting—Mycophenolic acid—psoriasis	7.78e-05	0.000247	CcSEcCtD
Zolpidem—Discomfort—Betamethasone—psoriasis	7.75e-05	0.000246	CcSEcCtD
Zolpidem—Discomfort—Dexamethasone—psoriasis	7.75e-05	0.000246	CcSEcCtD
Zolpidem—Dyspepsia—Hydrocortisone—psoriasis	7.74e-05	0.000246	CcSEcCtD
Zolpidem—Rash—Mycophenolic acid—psoriasis	7.72e-05	0.000245	CcSEcCtD
Zolpidem—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	7.71e-05	0.00511	CbGpPWpGaD
Zolpidem—Dermatitis—Mycophenolic acid—psoriasis	7.71e-05	0.000245	CcSEcCtD
Zolpidem—Pain—Prednisolone—psoriasis	7.7e-05	0.000245	CcSEcCtD
Zolpidem—Urticaria—Mycophenolate mofetil—psoriasis	7.67e-05	0.000244	CcSEcCtD
Zolpidem—Headache—Mycophenolic acid—psoriasis	7.67e-05	0.000244	CcSEcCtD
Zolpidem—Decreased appetite—Hydrocortisone—psoriasis	7.65e-05	0.000243	CcSEcCtD
Zolpidem—Pharyngitis—Methotrexate—psoriasis	7.64e-05	0.000243	CcSEcCtD
Zolpidem—Abdominal pain—Mycophenolate mofetil—psoriasis	7.63e-05	0.000243	CcSEcCtD
Zolpidem—Body temperature increased—Mycophenolate mofetil—psoriasis	7.63e-05	0.000243	CcSEcCtD
Zolpidem—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.61e-05	0.00503	CbGpPWpGaD
Zolpidem—Urinary tract disorder—Methotrexate—psoriasis	7.6e-05	0.000242	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Hydrocortisone—psoriasis	7.6e-05	0.000242	CcSEcCtD
Zolpidem—Fatigue—Hydrocortisone—psoriasis	7.59e-05	0.000241	CcSEcCtD
Zolpidem—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	7.58e-05	0.00502	CbGpPWpGaD
Zolpidem—Vision blurred—Prednisone—psoriasis	7.56e-05	0.00024	CcSEcCtD
Zolpidem—Urethral disorder—Methotrexate—psoriasis	7.55e-05	0.00024	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Triamcinolone—psoriasis	7.55e-05	0.00024	CcSEcCtD
Zolpidem—Pain—Hydrocortisone—psoriasis	7.52e-05	0.000239	CcSEcCtD
Zolpidem—Oedema—Betamethasone—psoriasis	7.52e-05	0.000239	CcSEcCtD
Zolpidem—Anaphylactic shock—Dexamethasone—psoriasis	7.52e-05	0.000239	CcSEcCtD
Zolpidem—Anaphylactic shock—Betamethasone—psoriasis	7.52e-05	0.000239	CcSEcCtD
Zolpidem—Oedema—Dexamethasone—psoriasis	7.52e-05	0.000239	CcSEcCtD
Zolpidem—Insomnia—Triamcinolone—psoriasis	7.49e-05	0.000238	CcSEcCtD
Zolpidem—Infection—Dexamethasone—psoriasis	7.47e-05	0.000238	CcSEcCtD
Zolpidem—Infection—Betamethasone—psoriasis	7.47e-05	0.000238	CcSEcCtD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—IL13—psoriasis	7.46e-05	0.00494	CbGpPWpGaD
Zolpidem—Ill-defined disorder—Prednisone—psoriasis	7.44e-05	0.000237	CcSEcCtD
Zolpidem—Paraesthesia—Triamcinolone—psoriasis	7.44e-05	0.000237	CcSEcCtD
Zolpidem—Feeling abnormal—Prednisolone—psoriasis	7.42e-05	0.000236	CcSEcCtD
Zolpidem—Visual impairment—Methotrexate—psoriasis	7.42e-05	0.000236	CcSEcCtD
Zolpidem—Anaemia—Prednisone—psoriasis	7.41e-05	0.000236	CcSEcCtD
Zolpidem—Shock—Betamethasone—psoriasis	7.4e-05	0.000235	CcSEcCtD
Zolpidem—Shock—Dexamethasone—psoriasis	7.4e-05	0.000235	CcSEcCtD
Zolpidem—Dyspnoea—Triamcinolone—psoriasis	7.39e-05	0.000235	CcSEcCtD
Zolpidem—Nervous system disorder—Dexamethasone—psoriasis	7.37e-05	0.000234	CcSEcCtD
Zolpidem—Nervous system disorder—Betamethasone—psoriasis	7.37e-05	0.000234	CcSEcCtD
Zolpidem—Agitation—Prednisone—psoriasis	7.37e-05	0.000234	CcSEcCtD
Zolpidem—Tachycardia—Betamethasone—psoriasis	7.34e-05	0.000233	CcSEcCtD
Zolpidem—Tachycardia—Dexamethasone—psoriasis	7.34e-05	0.000233	CcSEcCtD
Zolpidem—Angioedema—Prednisone—psoriasis	7.33e-05	0.000233	CcSEcCtD
Zolpidem—Hypersensitivity—Cyclosporine—psoriasis	7.29e-05	0.000232	CcSEcCtD
Zolpidem—Dyspepsia—Triamcinolone—psoriasis	7.29e-05	0.000232	CcSEcCtD
Zolpidem—Nausea—Mycophenolic acid—psoriasis	7.27e-05	0.000231	CcSEcCtD
Zolpidem—Hyperhidrosis—Betamethasone—psoriasis	7.27e-05	0.000231	CcSEcCtD
Zolpidem—Hyperhidrosis—Dexamethasone—psoriasis	7.27e-05	0.000231	CcSEcCtD
Zolpidem—Feeling abnormal—Hydrocortisone—psoriasis	7.25e-05	0.000231	CcSEcCtD
Zolpidem—Malaise—Prednisone—psoriasis	7.23e-05	0.00023	CcSEcCtD
Zolpidem—Vertigo—Prednisone—psoriasis	7.21e-05	0.000229	CcSEcCtD
Zolpidem—Eye disorder—Methotrexate—psoriasis	7.2e-05	0.000229	CcSEcCtD
Zolpidem—Gastrointestinal pain—Hydrocortisone—psoriasis	7.19e-05	0.000229	CcSEcCtD
Zolpidem—Syncope—Prednisone—psoriasis	7.19e-05	0.000229	CcSEcCtD
Zolpidem—CYP2D6—Biological oxidations—CYP2S1—psoriasis	7.19e-05	0.00476	CbGpPWpGaD
Zolpidem—Tinnitus—Methotrexate—psoriasis	7.18e-05	0.000228	CcSEcCtD
Zolpidem—Anorexia—Betamethasone—psoriasis	7.17e-05	0.000228	CcSEcCtD
Zolpidem—Anorexia—Dexamethasone—psoriasis	7.17e-05	0.000228	CcSEcCtD
Zolpidem—Urticaria—Prednisolone—psoriasis	7.16e-05	0.000228	CcSEcCtD
Zolpidem—Cardiac disorder—Methotrexate—psoriasis	7.15e-05	0.000227	CcSEcCtD
Zolpidem—Fatigue—Triamcinolone—psoriasis	7.14e-05	0.000227	CcSEcCtD
Zolpidem—CYP2C9—Biological oxidations—CYP2S1—psoriasis	7.13e-05	0.00472	CbGpPWpGaD
Zolpidem—Hypersensitivity—Mycophenolate mofetil—psoriasis	7.12e-05	0.000226	CcSEcCtD
Zolpidem—Asthenia—Cyclosporine—psoriasis	7.1e-05	0.000226	CcSEcCtD
Zolpidem—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	7.09e-05	0.0047	CbGpPWpGaD
Zolpidem—Pain—Triamcinolone—psoriasis	7.08e-05	0.000225	CcSEcCtD
Zolpidem—Loss of consciousness—Prednisone—psoriasis	7.05e-05	0.000224	CcSEcCtD
Zolpidem—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	7.03e-05	0.00466	CbGpPWpGaD
Zolpidem—Hypotension—Dexamethasone—psoriasis	7.02e-05	0.000223	CcSEcCtD
Zolpidem—Hypotension—Betamethasone—psoriasis	7.02e-05	0.000223	CcSEcCtD
Zolpidem—Pruritus—Cyclosporine—psoriasis	7e-05	0.000223	CcSEcCtD
Zolpidem—Urticaria—Hydrocortisone—psoriasis	6.99e-05	0.000222	CcSEcCtD
Zolpidem—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	6.97e-05	0.00462	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—CAT—psoriasis	6.96e-05	0.00461	CbGpPWpGaD
Zolpidem—Body temperature increased—Hydrocortisone—psoriasis	6.96e-05	0.000221	CcSEcCtD
Zolpidem—Abdominal pain—Hydrocortisone—psoriasis	6.96e-05	0.000221	CcSEcCtD
Zolpidem—Mediastinal disorder—Methotrexate—psoriasis	6.94e-05	0.000221	CcSEcCtD
Zolpidem—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	6.94e-05	0.00459	CbGpPWpGaD
Zolpidem—Asthenia—Mycophenolate mofetil—psoriasis	6.93e-05	0.00022	CcSEcCtD
Zolpidem—Hypertension—Prednisone—psoriasis	6.92e-05	0.00022	CcSEcCtD
Zolpidem—Chills—Methotrexate—psoriasis	6.91e-05	0.00022	CcSEcCtD
Zolpidem—PTGS1—Overview of nanoparticle effects—IL6—psoriasis	6.89e-05	0.00456	CbGpPWpGaD
Zolpidem—Musculoskeletal discomfort—Betamethasone—psoriasis	6.85e-05	0.000218	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Dexamethasone—psoriasis	6.85e-05	0.000218	CcSEcCtD
Zolpidem—Pruritus—Mycophenolate mofetil—psoriasis	6.83e-05	0.000217	CcSEcCtD
Zolpidem—Myalgia—Prednisone—psoriasis	6.83e-05	0.000217	CcSEcCtD
Zolpidem—Arthralgia—Prednisone—psoriasis	6.83e-05	0.000217	CcSEcCtD
Zolpidem—Feeling abnormal—Triamcinolone—psoriasis	6.83e-05	0.000217	CcSEcCtD
Zolpidem—Anxiety—Prednisone—psoriasis	6.8e-05	0.000216	CcSEcCtD
Zolpidem—Insomnia—Dexamethasone—psoriasis	6.8e-05	0.000216	CcSEcCtD
Zolpidem—Insomnia—Betamethasone—psoriasis	6.8e-05	0.000216	CcSEcCtD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	6.79e-05	0.00449	CbGpPWpGaD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	6.78e-05	0.000216	CcSEcCtD
Zolpidem—Diarrhoea—Cyclosporine—psoriasis	6.77e-05	0.000215	CcSEcCtD
Zolpidem—Paraesthesia—Dexamethasone—psoriasis	6.75e-05	0.000215	CcSEcCtD
Zolpidem—Paraesthesia—Betamethasone—psoriasis	6.75e-05	0.000215	CcSEcCtD
Zolpidem—Discomfort—Prednisone—psoriasis	6.75e-05	0.000215	CcSEcCtD
Zolpidem—Mental disorder—Methotrexate—psoriasis	6.75e-05	0.000215	CcSEcCtD
Zolpidem—Malnutrition—Methotrexate—psoriasis	6.7e-05	0.000213	CcSEcCtD
Zolpidem—Erythema—Methotrexate—psoriasis	6.7e-05	0.000213	CcSEcCtD
Zolpidem—Hypersensitivity—Prednisolone—psoriasis	6.64e-05	0.000211	CcSEcCtD
Zolpidem—Dyspepsia—Dexamethasone—psoriasis	6.62e-05	0.00021	CcSEcCtD
Zolpidem—Dyspepsia—Betamethasone—psoriasis	6.62e-05	0.00021	CcSEcCtD
Zolpidem—Diarrhoea—Mycophenolate mofetil—psoriasis	6.61e-05	0.00021	CcSEcCtD
Zolpidem—Urticaria—Triamcinolone—psoriasis	6.58e-05	0.000209	CcSEcCtD
Zolpidem—Dysgeusia—Methotrexate—psoriasis	6.56e-05	0.000209	CcSEcCtD
Zolpidem—Body temperature increased—Triamcinolone—psoriasis	6.55e-05	0.000208	CcSEcCtD
Zolpidem—Dizziness—Cyclosporine—psoriasis	6.55e-05	0.000208	CcSEcCtD
Zolpidem—Anaphylactic shock—Prednisone—psoriasis	6.55e-05	0.000208	CcSEcCtD
Zolpidem—Oedema—Prednisone—psoriasis	6.55e-05	0.000208	CcSEcCtD
Zolpidem—Decreased appetite—Betamethasone—psoriasis	6.53e-05	0.000208	CcSEcCtD
Zolpidem—Decreased appetite—Dexamethasone—psoriasis	6.53e-05	0.000208	CcSEcCtD
Zolpidem—Infection—Prednisone—psoriasis	6.5e-05	0.000207	CcSEcCtD
Zolpidem—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	6.5e-05	0.0043	CbGpPWpGaD
Zolpidem—Gastrointestinal disorder—Dexamethasone—psoriasis	6.49e-05	0.000206	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Betamethasone—psoriasis	6.49e-05	0.000206	CcSEcCtD
Zolpidem—Back pain—Methotrexate—psoriasis	6.48e-05	0.000206	CcSEcCtD
Zolpidem—Hypersensitivity—Hydrocortisone—psoriasis	6.48e-05	0.000206	CcSEcCtD
Zolpidem—Fatigue—Betamethasone—psoriasis	6.48e-05	0.000206	CcSEcCtD
Zolpidem—Fatigue—Dexamethasone—psoriasis	6.48e-05	0.000206	CcSEcCtD
Zolpidem—Shock—Prednisone—psoriasis	6.44e-05	0.000205	CcSEcCtD
Zolpidem—Pain—Dexamethasone—psoriasis	6.43e-05	0.000204	CcSEcCtD
Zolpidem—Pain—Betamethasone—psoriasis	6.43e-05	0.000204	CcSEcCtD
Zolpidem—Nervous system disorder—Prednisone—psoriasis	6.42e-05	0.000204	CcSEcCtD
Zolpidem—Tachycardia—Prednisone—psoriasis	6.39e-05	0.000203	CcSEcCtD
Zolpidem—Dizziness—Mycophenolate mofetil—psoriasis	6.39e-05	0.000203	CcSEcCtD
Zolpidem—Skin disorder—Prednisone—psoriasis	6.36e-05	0.000202	CcSEcCtD
Zolpidem—Hyperhidrosis—Prednisone—psoriasis	6.33e-05	0.000201	CcSEcCtD
Zolpidem—Vision blurred—Methotrexate—psoriasis	6.32e-05	0.000201	CcSEcCtD
Zolpidem—Asthenia—Hydrocortisone—psoriasis	6.31e-05	0.000201	CcSEcCtD
Zolpidem—Vomiting—Cyclosporine—psoriasis	6.29e-05	0.0002	CcSEcCtD
Zolpidem—Rash—Cyclosporine—psoriasis	6.24e-05	0.000199	CcSEcCtD
Zolpidem—Anorexia—Prednisone—psoriasis	6.24e-05	0.000198	CcSEcCtD
Zolpidem—Dermatitis—Cyclosporine—psoriasis	6.24e-05	0.000198	CcSEcCtD
Zolpidem—Pruritus—Hydrocortisone—psoriasis	6.22e-05	0.000198	CcSEcCtD
Zolpidem—Ill-defined disorder—Methotrexate—psoriasis	6.22e-05	0.000198	CcSEcCtD
Zolpidem—Headache—Cyclosporine—psoriasis	6.2e-05	0.000197	CcSEcCtD
Zolpidem—Anaemia—Methotrexate—psoriasis	6.2e-05	0.000197	CcSEcCtD
Zolpidem—Feeling abnormal—Betamethasone—psoriasis	6.19e-05	0.000197	CcSEcCtD
Zolpidem—Feeling abnormal—Dexamethasone—psoriasis	6.19e-05	0.000197	CcSEcCtD
Zolpidem—Gastrointestinal pain—Dexamethasone—psoriasis	6.15e-05	0.000196	CcSEcCtD
Zolpidem—Gastrointestinal pain—Betamethasone—psoriasis	6.15e-05	0.000196	CcSEcCtD
Zolpidem—Vomiting—Mycophenolate mofetil—psoriasis	6.14e-05	0.000195	CcSEcCtD
Zolpidem—Hypersensitivity—Triamcinolone—psoriasis	6.1e-05	0.000194	CcSEcCtD
Zolpidem—CYP1A2—Biological oxidations—CYP2S1—psoriasis	6.09e-05	0.00403	CbGpPWpGaD
Zolpidem—Rash—Mycophenolate mofetil—psoriasis	6.09e-05	0.000194	CcSEcCtD
Zolpidem—Dermatitis—Mycophenolate mofetil—psoriasis	6.08e-05	0.000194	CcSEcCtD
Zolpidem—Headache—Mycophenolate mofetil—psoriasis	6.05e-05	0.000192	CcSEcCtD
Zolpidem—Malaise—Methotrexate—psoriasis	6.04e-05	0.000192	CcSEcCtD
Zolpidem—Vertigo—Methotrexate—psoriasis	6.02e-05	0.000192	CcSEcCtD
Zolpidem—Diarrhoea—Hydrocortisone—psoriasis	6.02e-05	0.000191	CcSEcCtD
Zolpidem—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	6.01e-05	0.00398	CbGpPWpGaD
Zolpidem—Leukopenia—Methotrexate—psoriasis	6e-05	0.000191	CcSEcCtD
Zolpidem—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	6e-05	0.00397	CbGpPWpGaD
Zolpidem—Urticaria—Dexamethasone—psoriasis	5.97e-05	0.00019	CcSEcCtD
Zolpidem—Urticaria—Betamethasone—psoriasis	5.97e-05	0.00019	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Prednisone—psoriasis	5.96e-05	0.00019	CcSEcCtD
Zolpidem—Dizziness—Prednisolone—psoriasis	5.96e-05	0.000189	CcSEcCtD
Zolpidem—Asthenia—Triamcinolone—psoriasis	5.94e-05	0.000189	CcSEcCtD
Zolpidem—Abdominal pain—Dexamethasone—psoriasis	5.94e-05	0.000189	CcSEcCtD
Zolpidem—Abdominal pain—Betamethasone—psoriasis	5.94e-05	0.000189	CcSEcCtD
Zolpidem—Body temperature increased—Dexamethasone—psoriasis	5.94e-05	0.000189	CcSEcCtD
Zolpidem—Body temperature increased—Betamethasone—psoriasis	5.94e-05	0.000189	CcSEcCtD
Zolpidem—Insomnia—Prednisone—psoriasis	5.92e-05	0.000188	CcSEcCtD
Zolpidem—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	5.91e-05	0.00391	CbGpPWpGaD
Zolpidem—Nausea—Cyclosporine—psoriasis	5.88e-05	0.000187	CcSEcCtD
Zolpidem—Paraesthesia—Prednisone—psoriasis	5.88e-05	0.000187	CcSEcCtD
Zolpidem—Pruritus—Triamcinolone—psoriasis	5.86e-05	0.000186	CcSEcCtD
Zolpidem—Cough—Methotrexate—psoriasis	5.85e-05	0.000186	CcSEcCtD
Zolpidem—Dizziness—Hydrocortisone—psoriasis	5.82e-05	0.000185	CcSEcCtD
Zolpidem—Dyspepsia—Prednisone—psoriasis	5.76e-05	0.000183	CcSEcCtD
Zolpidem—Nausea—Mycophenolate mofetil—psoriasis	5.74e-05	0.000182	CcSEcCtD
Zolpidem—Myalgia—Methotrexate—psoriasis	5.71e-05	0.000182	CcSEcCtD
Zolpidem—Arthralgia—Methotrexate—psoriasis	5.71e-05	0.000182	CcSEcCtD
Zolpidem—Chest pain—Methotrexate—psoriasis	5.71e-05	0.000182	CcSEcCtD
Zolpidem—Decreased appetite—Prednisone—psoriasis	5.69e-05	0.000181	CcSEcCtD
Zolpidem—Rash—Prednisolone—psoriasis	5.68e-05	0.000181	CcSEcCtD
Zolpidem—Dermatitis—Prednisolone—psoriasis	5.67e-05	0.000181	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	5.67e-05	0.00018	CcSEcCtD
Zolpidem—Fatigue—Prednisone—psoriasis	5.64e-05	0.00018	CcSEcCtD
Zolpidem—Headache—Prednisolone—psoriasis	5.64e-05	0.00018	CcSEcCtD
Zolpidem—Discomfort—Methotrexate—psoriasis	5.64e-05	0.000179	CcSEcCtD
Zolpidem—Constipation—Prednisone—psoriasis	5.6e-05	0.000178	CcSEcCtD
Zolpidem—Vomiting—Hydrocortisone—psoriasis	5.59e-05	0.000178	CcSEcCtD
Zolpidem—Rash—Hydrocortisone—psoriasis	5.55e-05	0.000176	CcSEcCtD
Zolpidem—Dermatitis—Hydrocortisone—psoriasis	5.54e-05	0.000176	CcSEcCtD
Zolpidem—PTGS1—Selenium Micronutrient Network—CRP—psoriasis	5.53e-05	0.00366	CbGpPWpGaD
Zolpidem—Confusional state—Methotrexate—psoriasis	5.52e-05	0.000175	CcSEcCtD
Zolpidem—Headache—Hydrocortisone—psoriasis	5.51e-05	0.000175	CcSEcCtD
Zolpidem—Dizziness—Triamcinolone—psoriasis	5.48e-05	0.000174	CcSEcCtD
Zolpidem—Anaphylactic shock—Methotrexate—psoriasis	5.47e-05	0.000174	CcSEcCtD
Zolpidem—Infection—Methotrexate—psoriasis	5.44e-05	0.000173	CcSEcCtD
Zolpidem—Feeling abnormal—Prednisone—psoriasis	5.39e-05	0.000172	CcSEcCtD
Zolpidem—Asthenia—Betamethasone—psoriasis	5.39e-05	0.000172	CcSEcCtD
Zolpidem—Asthenia—Dexamethasone—psoriasis	5.39e-05	0.000172	CcSEcCtD
Zolpidem—Nervous system disorder—Methotrexate—psoriasis	5.37e-05	0.000171	CcSEcCtD
Zolpidem—Gastrointestinal pain—Prednisone—psoriasis	5.35e-05	0.00017	CcSEcCtD
Zolpidem—Nausea—Prednisolone—psoriasis	5.35e-05	0.00017	CcSEcCtD
Zolpidem—Pruritus—Dexamethasone—psoriasis	5.32e-05	0.000169	CcSEcCtD
Zolpidem—Pruritus—Betamethasone—psoriasis	5.32e-05	0.000169	CcSEcCtD
Zolpidem—Skin disorder—Methotrexate—psoriasis	5.31e-05	0.000169	CcSEcCtD
Zolpidem—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.3e-05	0.00351	CbGpPWpGaD
Zolpidem—Hyperhidrosis—Methotrexate—psoriasis	5.29e-05	0.000168	CcSEcCtD
Zolpidem—Vomiting—Triamcinolone—psoriasis	5.27e-05	0.000168	CcSEcCtD
Zolpidem—CYP1A2—Tryptophan metabolism—CAT—psoriasis	5.26e-05	0.00348	CbGpPWpGaD
Zolpidem—Nausea—Hydrocortisone—psoriasis	5.23e-05	0.000166	CcSEcCtD
Zolpidem—Rash—Triamcinolone—psoriasis	5.22e-05	0.000166	CcSEcCtD
Zolpidem—Dermatitis—Triamcinolone—psoriasis	5.22e-05	0.000166	CcSEcCtD
Zolpidem—Anorexia—Methotrexate—psoriasis	5.21e-05	0.000166	CcSEcCtD
Zolpidem—Urticaria—Prednisone—psoriasis	5.2e-05	0.000165	CcSEcCtD
Zolpidem—Headache—Triamcinolone—psoriasis	5.19e-05	0.000165	CcSEcCtD
Zolpidem—Body temperature increased—Prednisone—psoriasis	5.17e-05	0.000165	CcSEcCtD
Zolpidem—Abdominal pain—Prednisone—psoriasis	5.17e-05	0.000165	CcSEcCtD
Zolpidem—Diarrhoea—Dexamethasone—psoriasis	5.14e-05	0.000164	CcSEcCtD
Zolpidem—Diarrhoea—Betamethasone—psoriasis	5.14e-05	0.000164	CcSEcCtD
Zolpidem—Hypotension—Methotrexate—psoriasis	5.11e-05	0.000163	CcSEcCtD
Zolpidem—PTGS1—Selenium Micronutrient Network—ICAM1—psoriasis	5.08e-05	0.00336	CbGpPWpGaD
Zolpidem—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	5.02e-05	0.00332	CbGpPWpGaD
Zolpidem—Musculoskeletal discomfort—Methotrexate—psoriasis	4.98e-05	0.000159	CcSEcCtD
Zolpidem—Dizziness—Dexamethasone—psoriasis	4.97e-05	0.000158	CcSEcCtD
Zolpidem—Dizziness—Betamethasone—psoriasis	4.97e-05	0.000158	CcSEcCtD
Zolpidem—Insomnia—Methotrexate—psoriasis	4.95e-05	0.000157	CcSEcCtD
Zolpidem—Nausea—Triamcinolone—psoriasis	4.92e-05	0.000157	CcSEcCtD
Zolpidem—Paraesthesia—Methotrexate—psoriasis	4.91e-05	0.000156	CcSEcCtD
Zolpidem—Dyspnoea—Methotrexate—psoriasis	4.88e-05	0.000155	CcSEcCtD
Zolpidem—Somnolence—Methotrexate—psoriasis	4.86e-05	0.000155	CcSEcCtD
Zolpidem—Hypersensitivity—Prednisone—psoriasis	4.82e-05	0.000153	CcSEcCtD
Zolpidem—Dyspepsia—Methotrexate—psoriasis	4.82e-05	0.000153	CcSEcCtD
Zolpidem—Vomiting—Betamethasone—psoriasis	4.78e-05	0.000152	CcSEcCtD
Zolpidem—Vomiting—Dexamethasone—psoriasis	4.78e-05	0.000152	CcSEcCtD
Zolpidem—Decreased appetite—Methotrexate—psoriasis	4.76e-05	0.000151	CcSEcCtD
Zolpidem—Rash—Dexamethasone—psoriasis	4.74e-05	0.000151	CcSEcCtD
Zolpidem—Rash—Betamethasone—psoriasis	4.74e-05	0.000151	CcSEcCtD
Zolpidem—Dermatitis—Betamethasone—psoriasis	4.74e-05	0.000151	CcSEcCtD
Zolpidem—Dermatitis—Dexamethasone—psoriasis	4.74e-05	0.000151	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Methotrexate—psoriasis	4.72e-05	0.00015	CcSEcCtD
Zolpidem—Fatigue—Methotrexate—psoriasis	4.72e-05	0.00015	CcSEcCtD
Zolpidem—Headache—Dexamethasone—psoriasis	4.71e-05	0.00015	CcSEcCtD
Zolpidem—Headache—Betamethasone—psoriasis	4.71e-05	0.00015	CcSEcCtD
Zolpidem—CYP3A4—Biological oxidations—CYP2S1—psoriasis	4.7e-05	0.00311	CbGpPWpGaD
Zolpidem—Asthenia—Prednisone—psoriasis	4.7e-05	0.000149	CcSEcCtD
Zolpidem—Pain—Methotrexate—psoriasis	4.68e-05	0.000149	CcSEcCtD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—IL10—psoriasis	4.67e-05	0.00309	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	4.64e-05	0.00307	CbGpPWpGaD
Zolpidem—Pruritus—Prednisone—psoriasis	4.63e-05	0.000147	CcSEcCtD
Zolpidem—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.53e-05	0.003	CbGpPWpGaD
Zolpidem—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	4.51e-05	0.00298	CbGpPWpGaD
Zolpidem—Feeling abnormal—Methotrexate—psoriasis	4.51e-05	0.000143	CcSEcCtD
Zolpidem—Diarrhoea—Prednisone—psoriasis	4.48e-05	0.000142	CcSEcCtD
Zolpidem—Gastrointestinal pain—Methotrexate—psoriasis	4.47e-05	0.000142	CcSEcCtD
Zolpidem—Nausea—Dexamethasone—psoriasis	4.46e-05	0.000142	CcSEcCtD
Zolpidem—Nausea—Betamethasone—psoriasis	4.46e-05	0.000142	CcSEcCtD
Zolpidem—GABRB3—BDNF signaling pathway—NFKBIA—psoriasis	4.45e-05	0.00294	CbGpPWpGaD
Zolpidem—Urticaria—Methotrexate—psoriasis	4.35e-05	0.000138	CcSEcCtD
Zolpidem—Dizziness—Prednisone—psoriasis	4.33e-05	0.000138	CcSEcCtD
Zolpidem—Body temperature increased—Methotrexate—psoriasis	4.32e-05	0.000138	CcSEcCtD
Zolpidem—Abdominal pain—Methotrexate—psoriasis	4.32e-05	0.000138	CcSEcCtD
Zolpidem—Vomiting—Prednisone—psoriasis	4.16e-05	0.000132	CcSEcCtD
Zolpidem—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	4.15e-05	0.00275	CbGpPWpGaD
Zolpidem—Rash—Prednisone—psoriasis	4.13e-05	0.000131	CcSEcCtD
Zolpidem—Dermatitis—Prednisone—psoriasis	4.12e-05	0.000131	CcSEcCtD
Zolpidem—Headache—Prednisone—psoriasis	4.1e-05	0.00013	CcSEcCtD
Zolpidem—CYP3A4—Tryptophan metabolism—CAT—psoriasis	4.06e-05	0.00269	CbGpPWpGaD
Zolpidem—Hypersensitivity—Methotrexate—psoriasis	4.03e-05	0.000128	CcSEcCtD
Zolpidem—Asthenia—Methotrexate—psoriasis	3.93e-05	0.000125	CcSEcCtD
Zolpidem—Nausea—Prednisone—psoriasis	3.89e-05	0.000124	CcSEcCtD
Zolpidem—Pruritus—Methotrexate—psoriasis	3.87e-05	0.000123	CcSEcCtD
Zolpidem—PTGS1—Selenium Micronutrient Network—IFNG—psoriasis	3.87e-05	0.00256	CbGpPWpGaD
Zolpidem—Diarrhoea—Methotrexate—psoriasis	3.74e-05	0.000119	CcSEcCtD
Zolpidem—Dizziness—Methotrexate—psoriasis	3.62e-05	0.000115	CcSEcCtD
Zolpidem—GABRB2—Transmembrane transport of small molecules—CP—psoriasis	3.56e-05	0.00236	CbGpPWpGaD
Zolpidem—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	3.51e-05	0.00233	CbGpPWpGaD
Zolpidem—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.5e-05	0.00231	CbGpPWpGaD
Zolpidem—Vomiting—Methotrexate—psoriasis	3.48e-05	0.000111	CcSEcCtD
Zolpidem—Rash—Methotrexate—psoriasis	3.45e-05	0.00011	CcSEcCtD
Zolpidem—Dermatitis—Methotrexate—psoriasis	3.45e-05	0.00011	CcSEcCtD
Zolpidem—Headache—Methotrexate—psoriasis	3.43e-05	0.000109	CcSEcCtD
Zolpidem—GABRA3—Transmembrane transport of small molecules—CP—psoriasis	3.39e-05	0.00225	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—CARM1—psoriasis	3.39e-05	0.00225	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—CP—psoriasis	3.34e-05	0.00221	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—CP—psoriasis	3.31e-05	0.00219	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—CP—psoriasis	3.25e-05	0.00215	CbGpPWpGaD
Zolpidem—Nausea—Methotrexate—psoriasis	3.25e-05	0.000103	CcSEcCtD
Zolpidem—GABRA3—Transmembrane transport of small molecules—CARM1—psoriasis	3.24e-05	0.00214	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—NFKB1—psoriasis	3.22e-05	0.00213	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—CARM1—psoriasis	3.18e-05	0.00211	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—CARM1—psoriasis	3.16e-05	0.00209	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—CARM1—psoriasis	3.1e-05	0.00205	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—JUN—psoriasis	2.95e-05	0.00195	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	2.92e-05	0.00193	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—CP—psoriasis	2.84e-05	0.00188	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—NFKB1—psoriasis	2.84e-05	0.00188	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—NDUFA5—psoriasis	2.81e-05	0.00186	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—NDUFA5—psoriasis	2.73e-05	0.00181	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—CARM1—psoriasis	2.71e-05	0.0018	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—CXCL8—psoriasis	2.55e-05	0.00169	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—STAT3—psoriasis	2.55e-05	0.00169	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.54e-05	0.00168	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	2.52e-05	0.00167	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—TNF—psoriasis	2.5e-05	0.00166	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	2.43e-05	0.00161	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CYP2S1—psoriasis	2.39e-05	0.00158	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—JUN—psoriasis	2.37e-05	0.00157	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CYP2S1—psoriasis	2.32e-05	0.00154	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—NFKB1—psoriasis	2.28e-05	0.00151	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	2.2e-05	0.00146	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—VEGFA—psoriasis	2.07e-05	0.00137	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—NDUFA5—psoriasis	2.03e-05	0.00135	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—IL6—psoriasis	2.02e-05	0.00134	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	1.89e-05	0.00125	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	1.89e-05	0.00125	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—TNF—psoriasis	1.78e-05	0.00118	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CYP2S1—psoriasis	1.73e-05	0.00115	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—NDUFA5—psoriasis	1.57e-05	0.00104	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.47e-05	0.000971	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—NDUFA5—psoriasis	1.45e-05	0.000958	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—NDUFA5—psoriasis	1.43e-05	0.000949	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—IL6—psoriasis	1.43e-05	0.000949	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CYP2S1—psoriasis	1.34e-05	0.000885	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.34e-05	0.000885	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CYP2S1—psoriasis	1.23e-05	0.000814	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—NDUFA5—psoriasis	1.23e-05	0.000811	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CYP2S1—psoriasis	1.22e-05	0.000807	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.22e-05	0.000805	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CARM1—psoriasis	1.17e-05	0.000774	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.14e-05	0.000756	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CARM1—psoriasis	1.13e-05	0.00075	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.06e-05	0.000701	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CYP2S1—psoriasis	1.04e-05	0.00069	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—NDUFA5—psoriasis	9.46e-06	0.000626	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CARM1—psoriasis	8.45e-06	0.000559	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CYP2S1—psoriasis	8.04e-06	0.000532	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CAT—psoriasis	7.19e-06	0.000476	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.01e-06	0.000464	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CAT—psoriasis	6.97e-06	0.000461	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CARM1—psoriasis	6.53e-06	0.000432	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.39e-06	0.000423	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.1e-06	0.000404	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CARM1—psoriasis	6.01e-06	0.000398	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CARM1—psoriasis	5.96e-06	0.000394	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—APOE—psoriasis	5.59e-06	0.00037	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.57e-06	0.000368	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.46e-06	0.000361	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—APOE—psoriasis	5.41e-06	0.000358	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CAT—psoriasis	5.2e-06	0.000344	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CARM1—psoriasis	5.09e-06	0.000337	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PPARG—psoriasis	4.86e-06	0.000322	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.76e-06	0.000315	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PPARG—psoriasis	4.72e-06	0.000312	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—APOE—psoriasis	4.04e-06	0.000267	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CAT—psoriasis	4.02e-06	0.000266	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CARM1—psoriasis	3.93e-06	0.00026	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CAT—psoriasis	3.69e-06	0.000245	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CAT—psoriasis	3.66e-06	0.000242	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PPARG—psoriasis	3.52e-06	0.000233	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CAT—psoriasis	3.13e-06	0.000207	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—APOE—psoriasis	3.12e-06	0.000207	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—APOE—psoriasis	2.87e-06	0.00019	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—APOE—psoriasis	2.85e-06	0.000188	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PPARG—psoriasis	2.72e-06	0.00018	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PPARG—psoriasis	2.5e-06	0.000166	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PPARG—psoriasis	2.48e-06	0.000164	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—APOE—psoriasis	2.43e-06	0.000161	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CAT—psoriasis	2.42e-06	0.00016	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PPARG—psoriasis	2.12e-06	0.00014	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—APOE—psoriasis	1.88e-06	0.000124	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PPARG—psoriasis	1.63e-06	0.000108	CbGpPWpGaD
